The DOI matches its Crossref record; 199 of the 199 references it cites were found in a registry or an index.
Genetically Engineered Phages: a Review of Advances over the Last Decade
Open accessAbstract
SUMMARY: Soon after their discovery in the early 20th century, bacteriophages were recognized to have great potential as antimicrobial agents, a potential that has yet to be fully realized. The nascent field of phage therapy was adversely affected by inadequately controlled trials and the discovery of antibiotics. Although the study of phages as anti-infective agents slowed, phages played an important role in the development of molecular biology. In recent years, the increase in multidrug-resistant bacteria has renewed interest in the use of phages as antimicrobial agents. With the wide array of possibilities offered by genetic engineering, these bacterial viruses are being modified to precisely control and detect bacteria and to serve as new sources of antibacterials. In applications that go beyond their antimicrobial activity, phages are also being developed as vehicles for drug delivery and vaccines, as well as for the assembly of new materials. This review highlights advances in techniques used to engineer phages for all of these purposes and discusses existing challenges and opportunities for future work.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167 · cited 1×
“Biofilms can be less susceptible than planktonic bacteria to antimicrobial agents, including phages and antibiotics (118).”
BackgroundCRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947
Origins and evolution of antibiotic resistance
Davies, J., & Davies, D. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00016-10 · Cited by 5,784
Antibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., & Walter, P. (2007) · W.W. Norton eBooks · doi:10.1201/9780203833445 · Cited by 4,589
Next-generation DNA sequencing
Shendure, J., & Ji, H. (2008) · Nature Biotechnology · doi:10.1038/nbt1486 · Cited by 4,509
Antibacterial resistance worldwide: causes, challenges and responses
Levy, S. B., & Marshall, B. (2004) · Nature Medicine · doi:10.1038/nm1145 · Cited by 4,052
Biofilm formation as microbial development
O'Toole, G., Kaplan, H. B., & Kolter, R. (2000) · Annual Review of Microbiology · doi:10.1146/annurev.micro.54.1.49 · Cited by 3,571
The Involvement of Cell-to-Cell Signals in the Development of a Bacterial Biofilm
Davies, D. G., Parsek, M. R., Pearson, J. P., Iglewski, B. H., Costerton, J. W., & Greenberg, E. P. (1998) · Science · doi:10.1126/science.280.5361.295 · Cited by 3,396 · cited 1×
“T7 phage has also been engineered to encode an enzyme that interferes with quorum sensing (122), a bacterial cell-cell communication process involved in biofilm formation (123, 124).”
BackgroundThe crisis in antibiotic resistance
Neu, H. C. (1992) · Science · doi:10.1126/science.257.5073.1064 · Cited by 2,834
CRISPR/Cas, the Immune System of Bacteria and Archaea
Horvath, P., & Barrangou, R. (2010) · Science · doi:10.1126/science.1179555 · Cited by 2,465
Bacteriophage resistance mechanisms
Labrie, S. J., Samson, J. E., & Moineau, S. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2315 · Cited by 2,397
Evolution and classification of the CRISPR–Cas systems
Makarova, K. S., Haft, D. H., Barrangou, R., Brouns, S. J. J., Charpentier, E., Horvath, P., Moineau, S., Mojica, F. J. M., Wolf, Y. I., Yakunin, A. F., et al. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2577 · Cited by 2,331
The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA
Garneau, J. E., Dupuis, M.-È., Villion, M., Romero, D. A., Barrangou, R., Boyaval, P., Fremaux, C., Horvath, P., Magadán, A. H., & Moineau, S. (2010) · Nature · doi:10.1038/nature09523 · Cited by 2,328
The impact of next-generation sequencing technology on genetics
Mardis, E. R. (2008) · Trends in Genetics · doi:10.1016/j.tig.2007.12.007 · Cited by 2,053
Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012
Agents that increase the permeability of the outer membrane
Vaara, M. (1992) · Microbiological Reviews · doi:10.1128/mr.56.3.395-411.1992 · Cited by 1,879 · cited 1×
“There are two classes of outer membrane permeabilizers: (i) polycationic agents, such as polymyxin and its derivatives, which interact with phospholipids in the cell membrane (163, 164), or lysine polymers, which adsorb to the cell surface and block growth (164, 165); and (ii) chelators, such as EDTA, which remove ion…”
BackgroundVirus-Enabled Synthesis and Assembly of Nanowires for Lithium Ion Battery Electrodes
Nam, K. T., Kim, D.-W., Yoo, P. J., Chiang, C.-Y., Meethong, N., Hammond, P. T., Chiang, Y.-M., & Belcher, A. M. (2006) · Science · doi:10.1126/science.1122716 · Cited by 1,855
Alzheimer's Disease and the Amyloid-β Peptide
Murphy, M. P., & LeVine, H. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1221 · Cited by 1,750
Sulakvelidze, A., Alavidze, Z., & Morris, J. G. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.649-659.2001 · Cited by 1,566
Pathogen detection: A perspective of traditional methods and biosensors
Lazcka, O., Campo, F. J. D., & Muñoz, F. X. (2007) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2006.06.036 · Cited by 1,500
Watnick, P., & Kolter, R. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.10.2675-2679.2000 · Cited by 1,435
The antibiotic resistome: the nexus of chemical and genetic diversity
Wright, G. D. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1614 · Cited by 1,365
multifunctional enzymes in cancer
Mohamed, M. M., & Sloane, B. F. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1949 · Cited by 1,265
Friedberg, E. C. (2003) · Nature · doi:10.1038/nature01408 · Cited by 1,177
Clokie, M. R. J., Millard, A. D., Letarov, A. V., & Heaphy, S. (2011) · Bacteriophage · doi:10.4161/bact.1.1.14942 · Cited by 1,149
Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide
Butterfield, D. A., Drake, J., Pocernich, C., & Castegna, A. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02173-6 · Cited by 1,114
Quenching quorum-sensing-dependent bacterial infection by an N-acyl homoserine lactonase
Dong, Y.-H., Wang, L.-H., Xu, J.-L., Zhang, H.-B., Zhang, X.-F., & Zhang, L.-H. (2001) · Nature · doi:10.1038/35081101 · Cited by 1,064
The Alzheimer's Disease-Associated Amyloid β-Protein Is an Antimicrobial Peptide
Soscia, S. J., Kirby, J. E., Washicosky, K. J., Tucker, S. M., Ingelsson, M., Hyman, B., Burton, M. A., Goldstein, L. E., Duong, S., Tanzi, R. E., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009505 · Cited by 1,060
Pros and cons of phage therapy
Loc-Carrillo, C., & Abedon, S. T. (2011) · Bacteriophage · doi:10.4161/bact.1.2.14590 · Cited by 1,020
Ordering of Quantum Dots Using Genetically Engineered Viruses
Lee, S.-W., Mao, C., Flynn, C. E., & Belcher, A. M. (2002) · Science · doi:10.1126/science.1068054 · Cited by 998
Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials
Bikard, D., Euler, C. W., Jiang, W., Nussenzweig, P. M., Goldberg, G. W., Duportet, X., Fischetti, V. A., & Marraffini, L. A. (2014) · Nature Biotechnology · doi:10.1038/nbt.3043 · Cited by 986
Phage treatment of human infections
Abedon, S. T., Kuhl, S. J., Blasdel, B. G., & Kutter, E. M. (2011) · Bacteriophage · doi:10.4161/bact.1.2.15845 · Cited by 980
Phage Cocktails and the Future of Phage Therapy
Chan, B. K., Abedon, S. T., & Loc-Carrillo, C. (2013) · Future Microbiology · doi:10.2217/fmb.13.47 · Cited by 914
AN INVESTIGATION ON THE NATURE OF ULTRA-MICROSCOPIC VIRUSES.
Twort, F. W. (1915) · The Lancet · doi:10.1016/s0140-6736(01)20383-3 · Cited by 901
Dispersing biofilms with engineered enzymatic bacteriophage
Lu, T. K., & Collins, J. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704624104 · Cited by 895
Self-citationWright, A., Hawkins, C. H., Änggård, E. E., & Harper, D. R. (2009) · Clinical Otolaryngology · doi:10.1111/j.1749-4486.2009.01973.x · Cited by 864
Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
Tamma, P. D., Cosgrove, S. E., & Maragakis, L. L. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05041-11 · Cited by 836
Bacteriophage Host Range and Bacterial Resistance
Hyman, P., & Abedon, S. T. (2010) · Advances in Applied Microbiology · doi:10.1016/s0065-2164(10)70007-1 · Cited by 819
Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases
Citorik, R. J., Mimee, M., & Lu, T. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.3011 · Cited by 808 · cited 3×
“mellonella was significantly higher than that of controls (buffer treatment only or treatment with a RGN construct targeting an absent DNA sequence) (141).”
BackgroundSelf-citationRecombineering: a homologous recombination-based method of genetic engineering
Sharan, S. K., Thomason, L. C., Kuznetsov, S. G., & Court, D. L. (2009) · Nature Protocols · doi:10.1038/nprot.2008.227 · Cited by 785
Bacteriophage Endolysins as Novel Antimicrobials
Schmelcher, M., Donovan, D. M., & Loessner, M. J. (2012) · Future Microbiology · doi:10.2217/fmb.12.97 · Cited by 785
HIV vaccine design and the neutralizing antibody problem
Burton, D. R., Desrosiers, R. C., Doms, R. W., Koff, W. C., Kwong, P. D., Moore, J. P., Nabel, G. J., Sodroski, J., Wilson, I. A., & Wyatt, R. T. (2004) · Nature Immunology · doi:10.1038/ni0304-233 · Cited by 765
Fabricating Genetically Engineered High-Power Lithium-Ion Batteries Using Multiple Virus Genes
Lee, Y. J., Yi, H., Kim, W.-J., Kang, K., Yun, D. S., Strano, M. S., Ceder, G., & Belcher, A. M. (2009) · Science · doi:10.1126/science.1171541 · Cited by 748
Revenge of the phages: defeating bacterial defences
Samson, J. E., Magadán, A. H., Sabri, M., & Moineau, S. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3096 · Cited by 698
The nucleotide sequence of bacteriophage φX174
Sanger, F., Coulson, A. R., Friedmann, T., Air, G. M., Barrell, B. G., Brown, N. L., Fiddes, J. C., Hutchison, C. A., Slocombe, P. M., & Smith, M. (1978) · Journal of Molecular Biology · doi:10.1016/0022-2836(78)90346-7 · Cited by 693
Phage Therapy in Clinical Practice: Treatment of Human Infections
Kutter, E., De Vos, D., Gvasalia, G., Alavidze, Z., Gogokhia, L., Kuhl, S., & Abedon, S. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110790725401 · Cited by 670
CRISPR/Cas System and Its Role in Phage-Bacteria Interactions
Deveau, H., Garneau, J. E., & Moineau, S. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134123 · Cited by 623
Smith, H. O., Hutchison, C. A., Pfannkoch, C., & Venter, J. C. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2237126100 · Cited by 611
Wittebole, X., De Roock, S., & Opal, S. M. (2014) · Virulence · doi:10.4161/viru.25991 · Cited by 599
(1987) · International Journal of Biochemistry · doi:10.1016/0020-711x(87)90149-2 · Cited by 598
Nelson, D., Loomis, L., & Fischetti, V. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061038398 · Cited by 578
Human Volunteers Receiving Escherichia coli Phage T4 Orally: a Safety Test of Phage Therapy
Bruttin, A., & Brüssow, H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2874-2878.2005 · Cited by 563
Bacteriophage endolysins — current state of research and applications
Loessner, M. J. (2005) · Current Opinion in Microbiology · doi:10.1016/j.mib.2005.06.002 · Cited by 537
Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy
Lu, T. K., & Collins, J. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800442106 · Cited by 529
Self-citationRapid Killing of Streptococcus pneumoniae with a Bacteriophage Cell Wall Hydrolase
Loeffler, J. M., Nelson, D., & Fischetti, V. A. (2001) · Science · doi:10.1126/science.1066869 · Cited by 517
Long-circulating bacteriophage as antibacterial agents.
Merril, C. R., Biswas, B., Carlton, R., Jensen, N. C., Creed, G. J., Zullo, S., & Adhya, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3188 · Cited by 512
Viral assembly of oriented quantum dot nanowires
Mao, C., Flynn, C. E., Hayhurst, A., Sweeney, R., Qi, J., Georgiou, G., Iverson, B., & Belcher, A. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0832310100 · Cited by 496
Phage display: Concept, innovations, applications and future
Pande, J., Szewczyk, M. M., & Grover, A. K. (2010) · Biotechnology Advances · doi:10.1016/j.biotechadv.2010.07.004 · Cited by 492
Virus-based piezoelectric energy generation
Lee, B. Y., Zhang, J., Zueger, C., Chung, W.-J., Yoo, S. Y., Wang, E., Meyer, J., Ramesh, R., & Lee, S.-W. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.69 · Cited by 491
Bacteriophages as potential new therapeutics to replace or supplement antibiotics
Kutateladze, M., & Adamia, R. (2010) · Trends in Biotechnology · doi:10.1016/j.tibtech.2010.08.001 · Cited by 483
Bacteriophage lysins as effective antibacterials
Fischetti, V. A. (2008) · Current Opinion in Microbiology · doi:10.1016/j.mib.2008.09.012 · Cited by 477
Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial
Rhoads, D. D., Wolcott, R. D., Kuskowski, M. A., Wolcott, B. M., Ward, L. S., & Sulakvelidze, A. (2009) · Journal of Wound Care · doi:10.12968/jowc.2009.18.6.42801 · Cited by 468
Leverentz, B., Conway, W. S., Camp, M. J., Janisiewicz, W. J., Abuladze, T., Yang, M., Saftner, R., & Sulakvelidze, A. (2003) · Applied and Environmental Microbiology · doi:10.1128/aem.69.8.4519-4526.2003 · Cited by 445
Bacteriophage endolysins: A novel anti-infective to control Gram-positive pathogens
Fischetti, V. A. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2010.04.002 · Cited by 438
Engineering Modular Viral Scaffolds for Targeted Bacterial Population Editing
Ando, H., Lemire, S., Pires, D. P., & Lu, T. K. (2015) · Cell Systems · doi:10.1016/j.cels.2015.08.013 · Cited by 426
Self-citationEngineered Endolysin-Based “Artilysins” To Combat Multidrug-Resistant Gram-Negative Pathogens
Briers, Y., Walmagh, M., Van Puyenbroeck, V., Cornelissen, A., Cenens, W., Aertsen, A., Oliveira, H., Azeredo, J., Verween, G., Pirnay, J.-P., et al. (2014) · mBio · doi:10.1128/mbio.01379-14 · Cited by 421
Self-citationBacteriophage therapy: a revitalized therapy against bacterial infectious diseases
Matsuzaki, S., Rashel, M., Uchiyama, J., Sakurai, S., Ujihara, T., Kuroda, M., Imai, S., Ikeuchi, M., Tani, T., Fujieda, M., et al. (2005) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-005-0408-9 · Cited by 409
Phage Therapy—History from Twort and d'Herelle Through Soviet Experience to Current Approaches
Chanishvili, N. (2012) · Advances in Virus Research · doi:10.1016/b978-0-12-394438-2.00001-3 · Cited by 407
Bacteriophage lytic enzymes: novel anti-infectives
Fischetti, V. A. (2005) · Trends in Microbiology · doi:10.1016/j.tim.2005.08.007 · Cited by 400
Dang, X., Yi, H., Ham, M.-H., Qi, J., Yun, D. S., Ladewski, R., Strano, M. S., Hammond, P. T., & Belcher, A. M. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.50 · Cited by 396
?-Poly-l-lysine: microbial production, biodegradation and application potential
Yoshida, T., & Nagasawa, T. (2003) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-003-1312-9 · Cited by 387
Clinical Aspects of Phage Therapy
Międzybrodzki, R., Borysowski, J., Weber-Dąbrowska, B., Fortuna, W., Letkiewicz, S., Szufnarowski, K., Pawełczyk, Z., Rogóż, P., Kłak, M., Wojtasik, E., et al. (2012) · Advances in Virus Research · doi:10.1016/b978-0-12-394438-2.00003-7 · Cited by 373
Nelson, D. C., Schmelcher, M., Rodriguez-Rubio, L., Klumpp, J., Pritchard, D. G., Dong, S., & Donovan, D. M. (2012) · Advances in Virus Research · doi:10.1016/b978-0-12-394438-2.00007-4 · Cited by 372
Hatfull, G. F. (2008) · Current Opinion in Microbiology · doi:10.1016/j.mib.2008.09.004 · Cited by 371
Bacteriophage Therapy To Reduce Campylobacter jejuni Colonization of Broiler Chickens
Loc Carrillo, C., Atterbury, R. J., El-Shibiny, A., Connerton, P. L., Dillon, E., Scott, A., & Connerton, I. F. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.11.6554-6563.2005 · Cited by 367
Fu, W., Forster, T., Mayer, O., Curtin, J. J., Lehman, S. M., & Donlan, R. M. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00669-09 · Cited by 362
Chan, L. Y., Kosuri, S., & Endy, D. (2005) · Molecular Systems Biology · doi:10.1038/msb4100025 · Cited by 357
Quorum-Sensing Regulation of the Biofilm Matrix Genes (pel) of Pseudomonas aeruginosa
Sakuragi, Y., & Kolter, R. (2007) · Journal of Bacteriology · doi:10.1128/jb.00137-07 · Cited by 347
High-sensitivity bacterial detection using biotin-tagged phage and quantum-dot nanocomplexes
Edgar, R., McKinstry, M., Hwang, J., Oppenheim, A. B., Fekete, R. A., Giulian, G., Merril, C., Nagashima, K., & Adhya, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601211103 · Cited by 338
CRISPR–Cas systems: beyond adaptive immunity
Westra, E. R., Buckling, A., & Fineran, P. C. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3241 · Cited by 323
The next generation of bacteriophage therapy
Lu, T. K., & Koeris, M. S. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.07.028 · Cited by 312
Self-citationPhage Therapy of Pseudomonas aeruginosa Infection in a Mouse Burn Wound Model
McVay, C. S., Velásquez, M., & Fralick, J. A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01028-06 · Cited by 306
Mammalian Host-Versus-Phage immune response determines phage fate in vivo
Hodyra-Stefaniak, K., Miernikiewicz, P., Drapała, J., Drab, M., Jończyk-Matysiak, E., Lecion, D., Kaźmierczak, Z., Beta, W., Majewska, J., Harhala, M., et al. (2015) · Scientific Reports · doi:10.1038/srep14802 · Cited by 302
The Use of Phages for the Removal of Infectious Biofilms
Azeredo, J., & Sutherland, I. (2008) · Current Pharmaceutical Biotechnology · doi:10.2174/138920108785161604 · Cited by 292
Self-citationSur un microbe invisible antagoniste des bacilles dysenteriques
D'Herelle, M. F. (1961) · Americanae (AECID Library) · Cited by 288
M13-templated magnetic nanoparticles for targeted in vivo imaging of prostate cancer
Ghosh, D., Lee, Y., Thomas, S., Kohli, A. G., Yun, D. S., Belcher, A. M., & Kelly, K. A. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.146 · Cited by 284
Genital Chlamydia trachomatis infections
Bébéar, C., & de Barbeyrac, B. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02647.x · Cited by 283
Yi, H., Ghosh, D., Ham, M.-H., Qi, J., Barone, P. W., Strano, M. S., & Belcher, A. M. (2012) · Nano Letters · doi:10.1021/nl2031663 · Cited by 278
Curtin, J. J., & Donlan, R. M. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1268-1275.2006 · Cited by 276
Lood, R., Winer, B. Y., Pelzek, A. J., Diez-Martinez, R., Thandar, M., Euler, C. W., Schuch, R., & Fischetti, V. A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04641-14 · Cited by 272
Phage Lytic Enzyme Cpl-1 as a Novel Antimicrobial for Pneumococcal Bacteremia
Loeffler, J. M., Djurkovic, S., & Fischetti, V. A. (2003) · Infection and Immunity · doi:10.1128/iai.71.11.6199-6204.2003 · Cited by 269
A Method for Generation Phage Cocktail with Great Therapeutic Potential
Gu, J., Liu, X., Li, Y., Han, W., Lei, L., Yang, Y., Zhao, H., Gao, Y., Song, J., Lu, R., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031698 · Cited by 268
Phage as a Modulator of Immune Responses
Górski, A., Międzybrodzki, R., Borysowski, J., Dąbrowska, K., Wierzbicki, P., Ohams, M., Korczak-Kowalska, G., Olszowska-Zaremba, N., Łusiak-Szelachowska, M., Kłak, M., et al. (2012) · Advances in Virus Research · doi:10.1016/b978-0-12-394438-2.00002-5 · Cited by 266
Mechanisms of Bacterial Resistance to Antibiotics
Dever, L. A. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.151.5.886 · Cited by 266
Molecular Genetics of Bacteria
(1998) · Journal of Medical Microbiology · doi:10.1099/00222615-47-9-844a · Cited by 264
Virus‐Based Chemical and Biological Sensing
Mao, C., Liu, A., & Cao, B. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200900231 · Cited by 260
Ghosh, D., Bagley, A. F., Na, Y. J., Birrer, M. J., Bhatia, S. N., & Belcher, A. M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400821111 · Cited by 251
New strategies for combating multidrug-resistant bacteria
Wright, G. D., & Sutherland, A. D. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.04.004 · Cited by 243
SPARC in cancer biology: Its role in cancer progression and potential for therapy
Tai, I. T., & Tang, M. J. (2008) · Drug Resistance Updates · doi:10.1016/j.drup.2008.08.005 · Cited by 242
Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh
Sarker, S. A., McCallin, S., Barretto, C., Berger, B., Pittet, A.-C., Sultana, S., Krause, L., Huq, S., Bibiloni, R., Bruttin, A., et al. (2012) · Virology · doi:10.1016/j.virol.2012.09.002 · Cited by 240
Cheng, Q., Nelson, D., Zhu, S., & Fischetti, V. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.111-117.2005 · Cited by 233
BRED: A Simple and Powerful Tool for Constructing Mutant and Recombinant Bacteriophage Genomes
Marinelli, L. J., Piuri, M., Swigoňová, Z., Balachandran, A., Oldfield, L. M., van Kessel, J. C., & Hatfull, G. F. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003957 · Cited by 226
Carvalho, C. M., Gannon, B. W., Halfhide, D. E., Santos, S. B., Hayes, C. M., Roe, J. M., & Azeredo, J. (2010) · BMC Microbiology · doi:10.1186/1471-2180-10-232 · Cited by 223
Self-citationReversing Bacterial Resistance to Antibiotics by Phage-Mediated Delivery of Dominant Sensitive Genes
Edgar, R., Friedman, N., Molshanski-Mor, S., & Qimron, U. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.05741-11 · Cited by 217
Inhibition of Biofilm Formation by T7 Bacteriophages Producing Quorum-Quenching Enzymes
Pei, R., & Lamas-Samanamud, G. R. (2014) · Applied and Environmental Microbiology · doi:10.1128/aem.01434-14 · Cited by 216
Westwater, C., Kasman, L. M., Schofield, D. A., Werner, P. A., Dolan, J. W., Schmidt, M. G., & Norris, J. S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1301-1307.2003 · Cited by 214
Experimental phage therapy of burn wound infection: difficult first steps.
Rose, T., Verbeken, G., Vos, D. D., Merabishvili, M., Vaneechoutte, M., Lavigne, R., Jennes, S., Zizi, M., & Pirnay, J. (2014) · PubMed · Cited by 213
Chan, B. K., & Abedon, S. T. (2012) · Advances in Applied Microbiology · doi:10.1016/b978-0-12-394805-2.00001-4 · Cited by 212
Loessner, M. J., Rees, C. E., Stewart, G. S., & Scherer, S. (1996) · Applied and Environmental Microbiology · doi:10.1128/aem.62.4.1133-1140.1996 · Cited by 211
Further Investigations on the Nature of Ultra-Microscopic Viruses and their Cultivation
Twort, F. W. (1936) · Journal of Hygiene · doi:10.1017/s0022172400043606 · Cited by 210
Oliveira, H., Thiagarajan, V., Walmagh, M., Sillankorva, S., Lavigne, R., Neves-Petersen, M. T., Kluskens, L. D., & Azeredo, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108376 · Cited by 207
Self-citationUse of a bacteriophage cocktail to control Salmonella in food and the food industry
Spricigo, D. A., Bardina, C., Cortés, P., & Llagostera, M. (2013) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2013.05.009 · Cited by 201
Bacteriophage Therapy of Bacterial Infections: An Update of our Institute’s Experience
Weber-Dąbrowska, B., Mulczyk, M., & Górski, A. (2001) · Inflammation · doi:10.1007/978-94-015-9702-9_15 · Cited by 199
Genetically Engineered Nanofiber-Like Viruses For Tissue Regenerating Materials
Merzlyak, A., Indrakanti, S., & Lee, S.-W. (2009) · Nano Letters · doi:10.1021/nl8036728 · Cited by 196
Virus-Based Fabrication of Micro- and Nanofibers Using Electrospinning
Lee, S.-W., & Belcher, A. M. (2004) · Nano Letters · doi:10.1021/nl034911t · Cited by 195
The viriosphere, diversity, and genetic exchange within phage communities
Hambly, E., & Suttle, C. A. (2005) · Current Opinion in Microbiology · doi:10.1016/j.mib.2005.06.005 · Cited by 193
Therapy of Experimental Pseudomonas Infections with a Nonreplicating Genetically Modified Phage
Hagens, S., Habel, A., von Ahsen, U., von Gabain, A., & Bläsi, U. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3817-3822.2004 · Cited by 187
Hawkins, C., Harper, D., Burch, D., Änggård, E., & Soothill, J. (2010) · Veterinary Microbiology · doi:10.1016/j.vetmic.2010.05.014 · Cited by 183
Filamentous phage as vector-mediated antibody delivery to the brain
Frenkel, D., & Solomon, B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072027199 · Cited by 180
Application of bacteriophages for detection of foodborne pathogens
Schmelcher, M., & Loessner, M. J. (2014) · Bacteriophage · doi:10.4161/bact.28137 · Cited by 180
CRISPR-Cas: an efficient tool for genome engineering of virulent bacteriophages
Martel, B., & Moineau, S. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku628 · Cited by 178
Adriaenssens, E. M., Van Vaerenbergh, J., Vandenheuvel, D., Dunon, V., Ceyssens, P.-J., De Proft, M., Kropinski, A. M., Noben, J.-P., Maes, M., & Lavigne, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033227 · Cited by 177
Le, S., He, X., Tan, Y., Huang, G., Zhang, L., Lux, R., Shi, W., & Hu, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068562 · Cited by 172
Genome Replication, Synthesis, and Assembly of the Bacteriophage T7 in a Single Cell-Free Reaction
Shin, J., Jardine, P., & Noireaux, V. (2012) · ACS Synthetic Biology · doi:10.1021/sb300049p · Cited by 162
Stamped microbattery electrodes based on self-assembled M13 viruses
Nam, K. T., Wartena, R., Yoo, P. J., Liau, F. W., Lee, Y. J., Chiang, Y.-M., Hammond, P. T., & Belcher, A. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711620105 · Cited by 160
Briers, Y., Walmagh, M., & Lavigne, R. (2011) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2010.04931.x · Cited by 159
Efficient engineering of a bacteriophage genome using the type I-E CRISPR-Cas system
Kiro, R., Shitrit, D., & Qimron, U. (2014) · RNA Biology · doi:10.4161/rna.27766 · Cited by 158
Sarkis, G. J., Jacobs, W. R., & Hatfull, G. F. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02281.x · Cited by 158
Oda, M., Morita, M., Unno, H., & Tanji, Y. (2004) · Applied and Environmental Microbiology · doi:10.1128/aem.70.1.527-534.2004 · Cited by 155
Efficacy of Bacteriophage Therapy in a Model ofBurkholderia cenocepaciaPulmonary Infection
Carmody, L. A., Gill, J. J., Summer, E. J., Sajjan, U. S., Gonzalez, C. F., Young, R., & LiPuma, J. J. (2009) · The Journal of Infectious Diseases · doi:10.1086/649227 · Cited by 154
A New Look at Bacteriophage λ Genetic Networks
Court, D. L., Oppenheim, A. B., & Adhya, S. L. (2006) · Journal of Bacteriology · doi:10.1128/jb.01215-06 · Cited by 153
Targeted Drug-Carrying Bacteriophages as Antibacterial Nanomedicines
Yacoby, I., Bar, H., & Benhar, I. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00163-07 · Cited by 152
Targeting Antibacterial Agents by Using Drug-Carrying Filamentous Bacteriophages
Yacoby, I., Shamis, M., Bar, H., Shabat, D., & Benhar, I. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00169-06 · Cited by 152
Killing cancer cells by targeted drug-carrying phage nanomedicines
Bar, H., Yacoby, I., & Benhar, I. (2008) · BMC Biotechnology · doi:10.1186/1472-6750-8-37 · Cited by 149
Mahichi, F., Synnott, A. J., Yamamichi, K., Osada, T., & Tanji, Y. (2009) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2009.01588.x · Cited by 147
Chromosomal DNA deletion confers phage resistance to Pseudomonas aeruginosa
Le, S., Yao, X., Lu, S., Tan, Y., Rao, X., Li, M., Jin, X., Wang, J., Zhao, Y., Wu, N. C., et al. (2014) · Scientific Reports · doi:10.1038/srep04738 · Cited by 138
Barbirz, S., Müller, J. J., Uetrecht, C., Clark, A. J., Heinemann, U., & Seckler, R. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06311.x · Cited by 138
Carbon nanotubes as in vivo bacterial probes
Bardhan, N. M., Ghosh, D., & Belcher, A. M. (2014) · Nature Communications · doi:10.1038/ncomms5918 · Cited by 136
Alteration of tail fiber protein gp38 enables T2 phage to infect Escherichia coli O157:H7
Yoichi, M., Abe, M., Miyanaga, K., Unno, H., & Tanji, Y. (2004) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2004.08.003 · Cited by 136
Phage Therapy Is Effective against Infection by Mycobacterium ulcerans in a Murine Footpad Model
Trigo, G., Martins, T. G., Fraga, A. G., Longatto‐Filho, A., Castro, A. G., Azeredo, J., & Pedrosa, J. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002183 · Cited by 132
Self-citationBacteriophage therapy for the treatment of infections.
Górski, A., Międzybrodzki, R., Borysowski, J., et al. (2009) · PubMed · Cited by 129
Becker, S. C., Foster-Frey, J. A., Stodola, A. J., Anacker, D. C., & Donovan, D. M. (2009) · Gene · doi:10.1016/j.gene.2009.04.023 · Cited by 128
Virus‐Based Alignment of Inorganic, Organic, and Biological Nanosized Materials
Lee, S. ‐., Lee, S. K., & Belcher, A. M. (2003) · Advanced Materials · doi:10.1002/adma.200304818 · Cited by 126
Schmelcher, M., Powell, A. M., Camp, M. J., Pohl, C. S., & Donovan, D. M. (2015) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-6579-0 · Cited by 126
Recombineering: A powerful tool for modification of bacteriophage genomes
Marinelli, L. J., Hatfull, G. F., & Piuri, M. (2012) · Bacteriophage · doi:10.4161/bact.18778 · Cited by 124
Díez‐Martínez, R., de Paz, H. D., García‐Fernández, E., Bustamante, N., Euler, C. W., Fischetti, V. A., Menéndez, M., & García, P. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv038 · Cited by 121
Piuri, M., Jacobs, W. R., & Hatfull, G. F. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004870 · Cited by 120
Characterization of five novel endolysins from Gram-negative infecting bacteriophages
Walmagh, M., Boczkowska, B., Grymonprez, B., Briers, Y., Drulis‐Kawa, Z., & Lavigne, R. (2012) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-012-4294-7 · Cited by 119
Refactored M13 Bacteriophage as a Platform for Tumor Cell Imaging and Drug Delivery
Ghosh, D., Kohli, A. G., Moser, F., Endy, D., & Belcher, A. M. (2012) · ACS Synthetic Biology · doi:10.1021/sb300052u · Cited by 119
Alonso, A., Campanario, E., & Martínez, J. L. (1999) · Microbiology · doi:10.1099/00221287-145-10-2857 · Cited by 119
Pseudomonas aeruginosa Keratitis in Mice: Effects of Topical Bacteriophage KPP12 Administration
Fukuda, K., Ishida, W., Uchiyama, J., Rashel, M., Kato, S.-I., Morita, T., Muraoka, A., Sumi, T., Matsuzaki, S., Daibata, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047742 · Cited by 116
Phage control of dual species biofilms ofPseudomonas fluorescensandStaphylococcus lentus
Sillankorva, S., Neubauer, P. B., & Azeredo, J. (2010) · Biofouling · doi:10.1080/08927014.2010.494251 · Cited by 115
Self-citationTremblay, D. M., Tegoni, M., Spinelli, S., Campanacci, V., Blangy, S., Huyghe, C., Desmyter, A., Labrie, S., Moineau, S., & Cambillau, C. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.7.2400-2410.2006 · Cited by 114
In vivo recombineering of bacteriophage λ by PCR fragments and single-strand oligonucleotides
Oppenheim, A. B., Rattray, A. J., Bubunenko, M. G., Thomason, L. C., & Court, D. L. (2004) · Virology · doi:10.1016/j.virol.2003.11.007 · Cited by 109
Genetically modified filamentous phage as bactericidal agents: a pilot study
Hagens, S., & Bläsi, U. (2003) · Letters in Applied Microbiology · doi:10.1046/j.1472-765x.2003.01400.x · Cited by 109
A fully decompressed synthetic bacteriophage øX174 genome assembled and archived in yeast
Jaschke, P. R., Lieberman, E., Rodriguez, J., Sierra, A., & Endy, D. (2012) · Virology · doi:10.1016/j.virol.2012.09.020 · Cited by 109
Phage Lytic Enzyme Cpl‐1 for Antibacterial Therapy in Experimental Pneumococcal Meningitis
Grandgirard, D., Loeffler, J. M., Fischetti, V. A., & Leib, S. L. (2008) · The Journal of Infectious Diseases · doi:10.1086/587942 · Cited by 106
A bacteriophage detection tool for viability assessment of Salmonella cells
Fernandes, E., Martins, V. C., Nóbrega, C., Carvalho, C. M., Cardoso, F. A., Cardoso, S., Dias, J., Deng, D., Kluskens, L., Freitas, P. P., et al. (2013) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2013.08.053 · Cited by 103
Self-citationAssembly of Bacteriophage into Functional Materials
Yang, S. H., Chung, W., McFarland, S., & Lee, S. (2012) · The Chemical Record · doi:10.1002/tcr.201200012 · Cited by 102
Sathaliyawala, T., Rao, M., Maclean, D. M., Birx, D. L., Alving, C. R., & Rao, V. B. (2006) · Journal of Virology · doi:10.1128/jvi.00235-06 · Cited by 99
Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection
Paul, V. D., Sundarrajan, S., Rajagopalan, S. S., Hariharan, S., Kempashanaiah, N., Padmanabhan, S., Sriram, B., & Ramachandran, J. (2011) · BMC Microbiology · doi:10.1186/1471-2180-11-195 · Cited by 97
SPARC Is a Key Regulator of Proliferation, Apoptosis and Invasion in Human Ovarian Cancer
Chen, J., Wang, M., Xi, B., Xue, J., He, D., Zhang, J., & Zhao, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042413 · Cited by 94
Oliveira, A., Sereno, R., & Azeredo, J. (2010) · Veterinary Microbiology · doi:10.1016/j.vetmic.2010.05.015 · Cited by 94
Self-citationWang, J., Wang, L., Yang, M., Zhu, Y., Tomsia, A., & Mao, C. (2014) · Nano Letters · doi:10.1021/nl504358j · Cited by 90
Almeida, C., Cerqueira, L., Azevedo, N. F., & Vieira, M. J. (2012) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2012.11.014 · Cited by 88
Adaptive mutations produce resistance to ciprofloxacin
Riesenfeld, C. S., Everett, M., Piddock, L. J. V., & Hall, B. G. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.9.2059 · Cited by 87
Next generation sequencing technologies and the changing landscape of phage genomics
Klumpp, J., Fouts, D. E., & Sozhamannan, S. (2012) · Bacteriophage · doi:10.4161/bact.22111 · Cited by 84
Chiral Smectic C Structures of Virus-Based Films
Lee, S., Wood, B. M., & Belcher, A. M. (2002) · Langmuir · doi:10.1021/la026387w · Cited by 84
Structures and host-adhesion mechanisms of lactococcal siphophages
Spinelli, S., Veesler, D., Bebeacua, C., & Cambillau, C. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00003 · Cited by 84
Targeted Drug Delivery to Hepatocarcinoma In vivo by Phage-Displayed Specific Binding Peptide
Du, B., Han, H., Wang, Z., Kuang, L., Wang, L., Yu, L., Wu, M., Zhou, Z., & Qian, M. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0339 · Cited by 80
Engineered phage-based therapeutic materials inhibit Chlamydia trachomatis intracellular infection
Bhattarai, S. R., Yoo, S. Y., Lee, S., & Dean, D. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.054 · Cited by 79
Yang, H., Zhang, Y., Yu, J., Huang, Y., Zhang, X., & Wei, H. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01793-13 · Cited by 79
Comparative genomics and functional analysis of the 936 group of lactococcal Siphoviridae phages
Murphy, J., Bottacini, F., Mahony, J., Kelleher, P., Neve, H., Zomer, A., Nauta, A., & van Sinderen, D. (2016) · Scientific Reports · doi:10.1038/srep21345 · Cited by 78
Brève histoire de la phagothérapie
Dublanchet, A., & Fruciano, E. (2008) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2008.06.016 · Cited by 73
Fernandes, S., Proença, D., Cantante, C., Silva, F. A., Leandro, C., Lourenço, S., Milheiriço, C., de LENCASTRE, H., Cavaco‐Silva, P., Pimentel, M., et al. (2012) · Microbial Drug Resistance · doi:10.1089/mdr.2012.0025 · Cited by 73
A T3 and T7 Recombinant Phage Acquires Efficient Adsorption and a Broader Host Range
Lin, T., Lo, Y.-H., Tseng, P.-W., Chang, S., Lin, Y.-T., & Chen, T.-S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030954 · Cited by 73
Legrand, P., Collins, B., Blangy, S., Murphy, J., Spinelli, S., Gutiérrez, C., Richet, N., Kellenberger, C., Desmyter, A., Mahony, J., et al. (2016) · mBio · doi:10.1128/mbio.01781-15 · Cited by 73
Farenc, C., Spinelli, S., VINOGRADOV, E. V., Tremblay, D. M., Blangy, S., Sadovskaya, I., Moineau, S., & Cambillau, C. (2014) · Journal of Virology · doi:10.1128/jvi.00739-14 · Cited by 70
Bacteriophage recombineering in the lytic state using the lambda red recombinases
Fehér, T., Karcagi, I., Blattner, F. R., & Pósfai, G. (2011) · Microbial Biotechnology · doi:10.1111/j.1751-7915.2011.00292.x · Cited by 68
Vegge, C. S., Brøndsted, L., Neve, H., Grath, S. M., van Sinderen, D., & Vogensen, F. K. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.12.4187-4197.2005 · Cited by 67
Nanoscale bacteriophage biosensors beyond phage display
Lee, K. H., Lee, J., Song, J., & Hwang, M. P. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s51894 · Cited by 63
Wang, T., Hartner, W. C., Gillespie, J. W., Kulkarni, P. P., Yang, S., Mei, L. A., Petrenko, V. A., & Torchilin, V. P. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.08.009 · Cited by 62
Advancing bacteriophage-based microbial diagnostics with synthetic biology
Lu, T. K., Bowers, J., & Koeris, M. (2013) · Trends in biotechnology · doi:10.1016/j.tibtech.2013.03.009 · Cited by 61
Self-citationJaved, M. A., Poshtiban, S., Arutyunov, D., Evoy, S., & Szymanski, C. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069770 · Cited by 59
Dong, Q., Wang, J., Yang, H., et al. (2014) · Microbial Biotechnology · doi:10.1111/1751-7915.12166 · Cited by 58
Ren, Z., Tian, C. J., Zhu, Q.-S., Zhao, M., An, X., Nie, W., Ling, S. R., Zhu, M., Wu, J., Lan, H.-Y., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2007.12.053 · Cited by 54
Kim, M. S., Kim, Y. D., Hong, S. S., Park, K., Ko, K. S., & Myung, H. (2014) · Applied and Environmental Microbiology · doi:10.1128/aem.02606-14 · Cited by 52
Exploiting what phage have evolved to control gram-positive pathogens
Fischetti, V. A. (2011) · Bacteriophage · doi:10.4161/bact.1.4.17747 · Cited by 47
Chung, W., Merzlyak, A., & Lee, S. (2010) · Soft Matter · doi:10.1039/c0sm00199f · Cited by 46
Evaluation of Fluoromycobacteriophages for Detecting Drug Resistance in Mycobacterium tuberculosis
Rondón, L., Piuri, M., Jacobs, W. R., de Waard, J. H., Hatfull, G. F., & Takiff, H. E. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02476-10 · Cited by 45
Shin, H., Lee, J.-H., Yoon, H., Kang, D., & Ryu, S. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.02279-13 · Cited by 43
Phage Renaissance: New Hope against Antibiotic Resistance
Potera, C. (2013) · Environmental Health Perspectives · doi:10.1289/ehp.121-a48 · Cited by 42
Cryo-Electron Microscopy Structure of Lactococcal Siphophage 1358 Virion
Spinelli, S., Bebeacua, C., Orlov, I. M., Tremblay, D. M., Klaholz, B. P., Moineau, S., & Cambillau, C. (2014) · Journal of Virology · doi:10.1128/jvi.01040-14 · Cited by 42
Miyake, H., Hara, I., & Eto, H. (2004) · PubMed · Cited by 33
Genetically Engineered Phage Fibers and Coatings for Antibacterial Applications
Mao, J. Y., Belcher, A. M., & Vliet, K. J. V. (2009) · Advanced Functional Materials · doi:10.1002/adfm.200900782 · Cited by 30
Synthetic Phage for Tissue Regeneration
Yoo, S. Y., Merzlyak, A., & Lee, S. (2014) · Mediators of Inflammation · doi:10.1155/2014/192790 · Cited by 28
THE USE OF BACTERIOPHAGE FILTRATES IN THE TREATMENT OF SUPPURATIVE CONDITIONS
Rice, T. B. (1930) · The American Journal of the Medical Sciences · doi:10.1097/00000441-193003000-00005 · Cited by 27
Evolution and Classification of CRISPR-Cas Systems and Cas Protein Families
Makarova, K. S., & Koonin, E. V. (2012) · Springer eBooks · doi:10.1007/978-3-642-34657-6_3 · Cited by 14
Cited by
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
Pang, Z., Raudonis, R., Glick, B. R., Lin, T.-J., & Cheng, Z. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.013 · Cited by 2,306
Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria
Kortright, K. E., Chan, B. K., Koff, J. L., & Turner, P. E. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.01.014 · Cited by 1,212
Phage therapy: From biological mechanisms to future directions
Strathdee, S. A., Hatfull, G. F., Mutalik, V. K., & Schooley, R. T. (2023) · Cell · doi:10.1016/j.cell.2022.11.017 · Cited by 817
Sartor, R. B., & Wu, G. D. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.10.012 · Cited by 808
Alternatives to Conventional Antibiotics in the Era of Antimicrobial Resistance
Ghosh, C., Sarkar, P., Issa, R., & Haldar, J. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2018.12.010 · Cited by 661
Metadata
- Authors
- Pires, D. P., Cleto, S., Sillankorva, S., Azeredo, J., & Lu, T. K.
- Venue
- Microbiology and Molecular Biology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2016-09
- Volume
- 80
- Issue
- 3
- Pages
- 523-543
- ISSN
- 1092-2172 (ISSN-L)
- 1098-5557
- OpenAlex
- W2409985107
- Cited by
- 427
- References
- 199
- FWCI
- 3.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.